Jnba Financial Advisors Lowers stake in Baxter International Inc (BAX)

Baxter International Inc (BAX) : Jnba Financial Advisors reduced its stake in Baxter International Inc by 45.34% during the most recent quarter end. The investment management company now holds a total of 3,195 shares of Baxter International Inc which is valued at $138,407 after selling 2,650 shares in Baxter International Inc , the firm said in a disclosure report filed with the SEC on Apr 21, 2016.Baxter International Inc makes up approximately 0.05% of Jnba Financial Advisors’s portfolio.

Baxter International Inc opened for trading at $44.34 and hit $44.78 on the upside on Wednesday, eventually ending the session at $44.18, with a gain of 0.48% or 0.21 points. The heightened volatility saw the trading volume jump to 1,19,37,938 shares. Company has a market cap of $24,205 M.

Other Hedge Funds, Including , Seaward Management Limited Partnership reduced its stake in BAX by selling 6,173 shares or 9.84% in the most recent quarter. The Hedge Fund company now holds 56,592 shares of BAX which is valued at $2,451,565. Baxter International Inc makes up approx 0.13% of Seaward Management Limited Partnership’s portfolio.Leavell Investment Management boosted its stake in BAX in the latest quarter, The investment management firm added 28 additional shares and now holds a total of 14,782 shares of Baxter International Inc which is valued at $640,356. Baxter International Inc makes up approx 0.09% of Leavell Investment Management’s portfolio.Gemmer Asset Management reduced its stake in BAX by selling 1 shares or 0.56% in the most recent quarter. The Hedge Fund company now holds 177 shares of BAX which is valued at $7,556.Integral Derivatives reduced its stake in BAX by selling 400 shares or 1.8% in the most recent quarter. The Hedge Fund company now holds 21,884 shares of BAX which is valued at $934,228. Baxter International Inc makes up approx 0.38% of Integral Derivatives’s portfolio.Charter Trust Co boosted its stake in BAX in the latest quarter, The investment management firm added 1,570 additional shares and now holds a total of 19,919 shares of Baxter International Inc which is valued at $835,403. Baxter International Inc makes up approx 0.10% of Charter Trust Co’s portfolio.

On the company’s financial health, Baxter International Inc reported $0.36 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Apr 26, 2016. Analyst had a consensus of $0.29. The company had revenue of $2375.00 million for the quarter, compared to analysts expectations of $2351.22 million. The company’s revenue was down -1.2 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.00 EPS.

Many Wall Street Analysts have commented on Baxter International Inc. Company shares were Reiterated by RBC Capital Mkts on Apr 27, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 47 from a previous price target of $40 .Baxter International Inc was Upgraded by Piper Jaffray to ” Overweight” on Apr 14, 2016. Company shares were Reiterated by RBC Capital Mkts on Feb 3, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 40 from a previous price target of $37 .

Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment which include three commercial franchises: Hemophilia BioTherapeutics and BioSurgery and Medical Products segment which include four commercial franchises: Fluid Systems Renal Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies alpha-1 antitrypsin deficiency burns and shock and other chronic and acute blood-related conditions and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets premixed drugs and drug-reconstitution systems pre-filled vials and syringes for injectable drugs IV nutrition products infusion pumps and inhalation anesthetics. Its products are used in hospitals kidney dialysis centers and nursing homes among others.

Leave a Reply

Baxter International Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Baxter International Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.